A clinical grade IHC assay for PTEN was able to identify cases with heterogeneous PTEN gene deletion in a subset of tumour glands as well as loss of PTEN protein in tumours with normal copy number, which potentially arose due to epigenetic or microRNA-mediated mechanisms.41 The gene discussed is PTEN; the disease is neoplasm.